PLASMA SOLUBLE LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 LEVELS MEASUREMENT FOR THE EARLY DIAGNOSIS OF ST ELEVATION MYOCARDIAL INFARCTION: COMPARATIVE STUDY WITH MYOCARDIAL NECROSES MARKERS  by Kobayashi, Nobuaki et al.
A106.E991
JACC March 9, 2010
Volume 55, issue 10A
 MYOCARDIAL ISCHEMIA AND INFARCTION 
PLASMA SOLUBLE LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 LEVELS 
MEASUREMENT FOR THE EARLY DIAGNOSIS OF ST ELEVATION MYOCARDIAL INFARCTION: 
COMPARATIVE STUDY WITH MYOCARDIAL NECROSES MARKERS
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 3:30 p.m.-4:30 p.m.
Session Title: Novel Biomarkers for Diagnosis and Risk Stratification in ACS
Abstract Category: Unstable Ischemic Syndrome--Clinical
Presentation Number: 1098-256
Authors: Nobuaki Kobayashi, Noritake Hata, Yoshihiko Seino, Noriaki Kume, Takuro Shinada, Yasuhiro Takahashi, Kyoichi Mizuno, Chiba Hokusoh 
Hospital, Nippon Medical School, Chiba, Japan
Background: Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) has not been precisely compared with other biomarkers at 
early stages of ST elevation myocardial infarction (STEMI).
Methods: The aims of this study were to clarify the diagnostic value of sLOX-1 at the earliest stage of STEMI, and time-dependent changes 
compared with other myocardial necrotic markers.
Results: Time-dependent changes were compared among sLOX-1, heart type fatty acid-banding protein (H-FABP), myoglobin, troponin T, and 
creatine kinase MB (CK-MB) in 22 STEMI patients. The sLOX-1 cut-off value to diagnose STEMI was calculated by another patient set consisting of 
12 STEMI and 138 controls. At the ER arrival (100±55minutes from the onset), sLOX-1 showed 91% sensitivity for diagnosis of STEMI. In contrast, 
H-FABP, myoglobin, troponin T, and CK-MB showed 73%, 64%, 45%, and 18% sensitivities to diagnose STEMI, respectively. At 6 hours after ER arrival, 
diagnostic sensitivities for sLOX-1, H-FABP, myoglobin, troponin T and CK-MB were 100%, 91%, 91%, 95%, and 91%, respectively. All these biomarkers 
kept high sensitivities (86-100%) until 12 hours after the ER arrival. At 24 hours after the ER arrival, diagnostic sensitivities of sLOX-1, troponin T and 
CK-MB remained 91%, 100% and 91%, respectively; however, those of H-FABP and myoglobin reduced to 68%.
Conclusions: At the earliest stage, sLOX-1 is the best biomarker to diagnose STEMI.
